IJEHS has been selected by our panelist as the first journal of the Top 30 Epidemiology Journals in 2023 on the web by Feedspot. Please visit https://blog.feedspot.com/epidemiology_journals/?_src=searchor Feedspot Reader
In February 2021, IJEHS obtained DOI from Crossref. All articles of IJEHS have crossref doi.
A question asked by IJEHS during the EMA Public stakeholder meeting on the assessment, approval, and roll-out of pandemic (COVID-19) vaccines
On Friday, January 8 2021, the European Medicines Agency (EMA) held a public stakeholder meeting on the assessment, approval, and roll-out of pandemic (COVID-19) vaccines. During this virtual public meeting, our journal asked the following question: 'How can you find out whether the patients from the placebo group and vaccine group had the same chance of being infected with the virus? If this was taken into account during the study, how exactly was it done?' In order to ...